Cardiomyopathies and Heart Failure - Biomolecular, Infectious and Immune Mechanisms

by Springer US
State: New
£129.36
VAT included - FREE Shipping
Springer US Cardiomyopathies and Heart Failure - Biomolecular, Infectious and Immune Mechanisms
Springer US - Cardiomyopathies and Heart Failure - Biomolecular, Infectious and Immune Mechanisms

Do you like this product? Spread the word!

£129.36 incl. VAT
Only 1 items available Only 1 items available
Delivery: between Wednesday, 27 October 2021 and Friday, 29 October 2021
Sales & Shipping: Dodax

Description


DUCTORYCHAPTER CARDIOMYOPATHIESANDHEARTFAILURE Biomolecular,InfectiousandImmuneMechanisms AkiraMatsumori,MD,PhD DepartmentofCardiovascularMedicine KyotoUniversityGraduateSchoolofMedicine Kyoto,Japan 1 SUMMARY Theclinicalpresentationofviralmyocarditisisvariable. Whenmyocardial necrosis is diffuse, congestive heart failure develops, and later, dilated cardiomyopathy. If the myocardial lesions are localized, a ventricular aneurysmforms. Whencomplicatedbyarrhythmias,myocarditispresentsas arrhythmogenic right ventricular cardiomyopathy. When myocardial necrosisislocalizedtothesubendocardialregion,restrictivecardiomyopathy may develop. While it has not been established that hypertrophic cardiomyopathy maybeacomplicationofviral myocarditis, asymmetrical septal hypertrophy has, in fact, sometimesbeen observed in patients with myocarditis. TheimportanceofhepatitisCvirusinfectionhasrecentlybeen notedinpatientswithmyocarditis,dilatedandhypertrophiccardiomyopathy.

Further information

Illustrations Note:
57 SW-Abb., 25 Farbabb.
Language:
English
Number of Pages:
531
Editor:
Matsumori, Akira;Matsumori
Media Type:
Softcover
Publisher:
Springer US

Master Data

Product Type:
Paperback book
Release date:
13 October 2012
Package Dimensions:
0.234 x 0.154 x 0.02 m; 0.821 kg
GTIN:
09781461348658
DUIN:
VVVH1IJLSDP
£129.36
We use cookies on our website to make our services more efficient and more user-friendly. Therefore please select "Accept cookies"! Please read our Privacy Policy for further information.